Medpace Holdings, Inc.
MEDP
Rank in Stocks
#1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Share Price
$622.03
Last synced: 2026-10-20
Market Cap
$17.36B
Change (1 day)
0.38%
Change (1 year)
14.00%
Country
US
Trade Medpace Holdings, Inc. (MEDP)
Category
Healthcare
Revenue for Medpace Holdings, Inc. (MEDP)
Revenue in Jun 2026 TTM: $2.78B
According to Medpace Holdings, Inc. latest financial reports the company's current revenue (TTM) is $2.78B. In 2024 the company made a revenue of $2.11B an increase over the revenue in the year 2023 that was $1.89B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Medpace Holdings, Inc. from 2013 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $2.78B | 9.96% |
| 2025 | $2.53B | 19.97% |
| 2024 | $2.11B | 11.84% |
| 2023 | $1.89B | 29.17% |
| 2022 | $1.46B | 27.80% |
| 2021 | $1.14B | 23.38% |
| 2020 | $925.93M | 7.54% |
| 2019 | $860.97M | 22.19% |
| 2018 | $704.59M | 61.55% |
| 2017 | $436.15M | 3.46% |
| 2016 | $421.58M | 17.41% |
| 2015 | $359.06M | 23.80% |
| 2014 | $290.04M | 6.28% |
| 2013 | $272.89M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 1,565.39% |
US
|
|
| $25.11B | 802.39% |
US
|
|
| $2.71B | -2.70% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 164.96% |
US
|
